C-reactive protein in unstable angina pectoris and its relation to coronary angiographic severity and diffusion scores of coronary lesions;Kararsız anjina pektoris'de C-reaktif protein ve bunun koroner lezyonların koroner anjiyografik şiddeti ve yaygınlık derecesi ile ilişkisi

Anadolu Kardiyoloji Dergisi

Volumn 10, Issue 5, 2010, Pages 421-428

  Soysal, Dilek ^a   Karakuş, Volkan ^a   Yavaş, Hakan Haldun ^a   Biçeroǧlu, Serdar ^b   Köseoǧlu, Mehmet ^a   Yeşil, Murat ^a  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Atakalp Kalp Hastaliklari Hastanesi Kahramanlar   (Turkey)

Author keywords

Angiography; C reactive protein; Logistic regression analysis; Unstable angina

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; MALE; OBSERVATIONAL STUDY; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; TURBIDIMETRY; UNSTABLE ANGINA PECTORIS;

EID: 78049351191     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: 10.5152/akd.2010.140     Document Type: Article

References (44)

1. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992; 326: 242-50.
2. Malpartida F, Vivancos R, Urbano C, Mora J. Inflammation and plaque instability. Arch Cardiol Mex 2007; 77 (Supp 4): 16-22.
3. De Servi S, Mariani M, Mariani G, Mazzone A. C-Reactive protein. Increase in unstable coronary disease. Cause or effect? J Am Coll Cardiol 2005; 46: 1496-502.
4. Maseri A, Sanna T. The role of plaque fissures in unstable angina: fact or fiction? Eur Heart J 1998; (Supp K): K2-4.
5. Weissberg PL. Atherogenesis: current understanding of the causes of atheroma. Heart 2000; 83: 247-52.
6. Koenig W. Atherosclerosis involves more than just lipids: focus on inflammation. Eur Heart J 1999; 1 (Supp T): T19-T26.
7. Schnabel R, Rupprecht HJ, Lackner KJ, Lubos E, Bickel C, Meyer J, et al. for the AtheroGene Investigators. Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study. Eur Heart J 2005; 26: 241-9.
8. Hamm CW, Heeschen C, Falk E, Fox Keith AA. Acute coronary syndromes: Pathophysiology, diagnosis and risk stratification. In: Camm AJ, Lüscher TF, Serruys PW, editors. The ESC Textbook of Cardiovascular Medicine. 1st ed. Oxford: Blackwell; 2006. p. 333-60.
9. Arroyo-Espliguero R, Avanzas P, Quiles J, Kaski JC. Predictive value of coronary artery stenoses and C-reactive protein levels in patients with stable coronary artery disease. Atherosclerosis 2009; 204: 239-43.
10. Abdelmouttaleb I, Danchin N, Ilardo C, Aimone-Gastin I, Angioi M, Lozniewski A, et al. C-reactive protein and coronary artery disease: Additional evidence of the implication of an inflammatory process in acute coronary syndromes. Am Heart J 1999; 137: 346-51.
11. Braunwald E. Unstable angina: a classification. Circulation 1989; 80: 410-4.
12. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. European Society of Hypertension-European Society of Cardiology Guidelines Committee. J Hypertens 2003; 21: 1011-53.
13. Standards of medical care for patients with diabetes mellitus. American Diabetes Association. Diabetes Care 2003; 26 (supp 1): 33-50.
14. NIH: Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults-the evidence report. National Institutes of Health. Obes Res 1998; 2 (supp 6): 51S-209S.
15. Perk J, Rosengren A, Dallongeville J. Prevention of cardiovascular disease: Risk factor detection and modification. In: Camm AJ, Lüscher TF, Serruys PW, editors. The ESC Textbook of Cardiovascular Medicine. 1st ed. Oxford: Blackwell; 2006. p. 243-70.
16. Rose GA, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular survey methods. 2nd ed. Geneva: WHO; 1982.
17. Boersma E, Van de Werf F, Zijlstra F. Management of acute coronary syndromes. In: Camm AJ, Lüscher TF, Serruys PW, editors. The ESC Textbook of Cardiovascular Medicine. 1st ed. Oxford: Blackwell; 2006. p. 367-89.
18. Negri M, Sheiban I, Arigliano PL, Tonni S, Montresor G, Carlini S, et al. Interrelation between angiographic severity of coronary artery disease and plasma levels of insulin, C-peptide and plasminogen activator inhibitor-1. Am J Cardiol 1993; 72: 397-401.
19. Gaspardone A, Perino M, Ghini AS, Tomai F, Versaci F, Proietti I, et al. Exercise induced myocardial ischemia does not cause increase in C-reactive protein concentration. Heart 2000; 84: 668-9.
20. Koenig W, Sund M, Fröhlich M, Fischer HG, Löwel H, Döring A, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Circulation 1999; 99: 237-42.
21. Koh KK, Han SH, Quon MJ. Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions. J Am Coll Cardiol 2005; 46: 1978-85.
22. Ridker PM. High-sensitivity C-reactive protein. Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001; 103: 1813-8.
23. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836-43.
24. Horne BD, Muhlestein JB, Carlquist JF, Bair TL, Madsen TE, Hart NI, et al. Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery disease. J Am Coll Cardiol 2000; 36: 1774-80.
25. Danesh J, Muir J, Wong YK, Ward M, Gallimore JR, Pepys MB. Risk factors for coronary heart disease and acute-phase proteins. Eur Heart J 1999; 20: 954-9.
26. Ferreiros ER, Boissonnet CP, Pizarro R, Merletti PF, Corrado G, Cagide A. Independent prognostic value of elevated C-reactive protein in unstable angina. Circulation 1999; 100: 1958-63.
27. Cook NR, Buring JE, Ridker PM. The effect of including C-reactive protein in cardiovascular risk prediction models in women. Ann Intern Med 2006; 145:21-9.
28. Biasucci LM, Liuzzo G, Grillo RL, Caligiuri G, Rebuzzi AG, Buffon A, et al. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 1999; 99: 855-60.
29. Conkbayir C, Ongun A, Beton O, Kumbasar D, Tutar E, Atmaca Y, et al. The relation of CRP and homocysteine levels and multivessel disease in acute coronary syndrome. MN Cardiology 2006; 13: 4-14.
30. Haider AW, Roubenoff R, Wilson PW, Levy D, D'Agostino R, Silbershatz H, et al. Monocyte cytokine production, systemic inflammation and cardiovascular disease in very elderly men and women: The Framingham Heart Study. Eur J Cardiovasc Prev Rehabil 2004; 11: 214-5.
31. Zebrack JS, Muhlestein JB, Horne BD, Anderson JL. Intermountain Heart Collaboration Study Group. C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina. J Am Coll Cardiol 2002; 39: 632-7.
32. Katritsis D, Korovesis S, Giazitzoglou E, Parissis J, Kalivas P, Webb-Peploe MM, et al. C-reactive protein concentrations and angiographic characteristics of coronary lesions. Clin Chem 2001; 47: 882-6.
33. Veselka J, Prochazkova S, Duchonova R, Bolomova I, Urbanova T, Tesar D, et al. Relationship of C-reactive protein to presence and severity of coronary atherosclerosis in patients with stable angina pectoris or a pathological exercise test. Coron Artery Dis 2002; 13: 151-4.
34. Arroyo-Espliguero R, Avanzas P, Cosin-Sales J, Aldama G, Pizzi C, Kaski JC. C-reactive protein elevation and disease activity in patients with coronary artery disease. Eur Heart J 2004; 25: 401-8.
35. Gökçe M, Erdöl C, Örem C, Tekelioǧlu Y, Durmuş I, Kasap H. Inflammation and immune system response against ustable angina and its relationship with coronary angiographic findings. Jpn Heart J 2002; 43: 593-605.
36. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. An 8-year follow-up of 14719 initially healthy American women. Circulation 2003; 107: 391-7.
37. Ikonomidis I, Andreotti F, Nihoyannopoulos P. Reduction of daily life ischemia by aspirin in patients with angina: underlying link between thromboxane A2 and macrophage colony stimulating factor. Heart 2004; 90: 389-93.
38. Takeda T, Hoshida S, Nishino M, Tanouchi J, Otsu K, Hori M. Relationship between effects of statins, aspirin and angiotensin II modulators on high-sensitive C-reactive protein levels. Atherosclerosis 2003; 169: 155-8.
39. Li JJ, Jiang H, Huang CX, Fang CH, Tang QZ, Xia H, et al. Elevated level of plasma C-reactive protein in patients with unstable angina: its relations with coronary stenosis and lipid profile. Angiology 2002; 53: 265-72.
40. Çavuşoǧlu Y, Görenek B, Alpsoy S, Ünalir A, Ata N, Timuralp B. Evaluation of C-reactive protein, fibrinogen and antithrombin-III as risk factors for coronary artery disease. Isr Med Assoc J 2001; 3: 13-6.
41. Mulvihill NT, Foley JB, Murphy RT, Curtin R, Crean PA, Walsh M. Risk stratification in unstable angina and non-Q wave myocardial infarction using soluble cell adhesion molecules. Heart 2001; 85: 623-7.
42. Onat A, Sansoy V, Yildirim B, Keleş I, Uysal O, Hergenç G. C-reactive protein and coronary heart disease in Western Turkey. Am J Cardiol 2001; 88: 601-7.
43. Jahn J, Hellmann I, Maass M, Giannitsis E, Dalhoff K, Katus HA. Time dependent changes of hs-CRP serum concentration in patients with non-ST elevation acute coronary syndrome. Herz 2004; 29: 795-801.
44. Antman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP, et al. Cardiac specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Eng J Med 1996; 335: 1342-9.